DOACs outperform VKAs | HeartFlow to merge, go public in deal worth $2.4B | $103M to fight burnout

Hoping to shed new light on the debate between DOACs and VKAs, researchers in France examined data from more than 24,000 TAVR patients.

Once the transaction is finalized, the combined entity will go by the name HeartFlow Group and be listed on the New York Stock Exchange as “HFLO.”

The money is part of the American Rescue Plan, the $1.9 trillion COVID-19 relief bill President Joe Biden signed into law in March.

In fact, researchers found, most children were discharged from the hospital within a few days. 

The risk for recurrent stroke is nearly 8% in the first year after an ischemic stroke—and primary care teams play a big role in managing that risk.  

A team of cardiologists evaluated echocardiography data from more than 3,000 U.S. patients.

HHS recently warned some 130 healthcare organizations are running vulnerable systems, potentially exposing millions of patients to danger.

Corporations own half of U.S. medical practices, with PE and similar stakeholders producing the sharpest increase (32%) in acquisitions between 2019-2020.